Investigation of aminomethyl indole derivatives as hyaluronidase inhibitors

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 65 C, Issue 7-8, 2010, Pages 445-450

  Ölgen, Süreyya ^a   Kaessler, Andre ^b   Kiliç Kurt, Zühal ^a   Jose, Joachim ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cancer; Indole Derivatives; Inhibitors of Hyaluronidases

Indexed keywords

BENZOXAZOLE DERIVATIVE; ENZYME INHIBITOR; HYALURONOGLUCOSAMINIDASE; INDOLE DERIVATIVE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINAE; ENZYMOLOGY; ISOLATION AND PURIFICATION; KINETICS; MALE; PH; TESTIS;

ANIMALS; BENZOXAZOLES; CATTLE; ENZYME INHIBITORS; HYALURONOGLUCOSAMINIDASE; HYDROGEN-ION CONCENTRATION; INDOLES; KINETICS; MALE; TESTIS;

EID: 77954988550     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2010-7-805     Document Type: Article

References (26)

1. Algul O., Kaessler A., Apcin Y., Yilmaz A., and Jose J. (2008), Comparative studies on conventional and microwave synthesis of some benzimidazole, benzothiazole and indole derivatives and testing on inhibition of hyaluronidase. Molecules 13, 736-748.
2. Boregowda R. K., Appaiah H. N., Sidddaiah M., Kumarswamy S. B., Sunila S., Thimmaiah K. N., Girish S., and Kemparaju K. (2007), The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci. 80, 1921-1943.
3. Botzki A., Rigden D. J., Braun S., Nukui M., Salmen S., Hoechstetter J., Bernhardt G., Dove S., and Jedrzejas M. J. (2004), L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. J. Biol. Chem. 279, 45990-45997.
4. Botzki A., Salmen S., Bernhardt G., Buschauer A., and Dove S. (2005), Structure-based design of bacterial hyaluronan lyase inhibitors. QSAR Comb. Sci. 24, 458-469.
5. Braun S. (2005), New Inhibitors of Bacterial Hyaluronidases-Synthesis and Structure Activity Relationships. University of Regensburg Press, Regensburg, Germany.
6. DiMango S. and Sun H. (2006), The strength of weak interactions: aromatic fluorine in drug design. Curr. Top. Med. Chem. 6, 1473-1482.
7. Frost G. and Stern R. (1997), A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal. Biochem. 251, 263-269.
8. Gore M., A'Hern R., Stankiewicz M., and Slevin M. (1996), Tumour marker levels during marimastat therapy. Lancet 348, 263-264.
9. Grish K. S. and Kemparaju K. (2007), Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides. Biochemistry 70, 948-952.
10. Grish K. S., Kemparaju K., Nagaraju S., and Vishwanath B. S. (2009), Hyaluronidase inhibitors: A biological and therapeutic perspective. Curr. Med. Chem. 16, 2261-2228.
11. Hagmann W. K. (2008), The many roles for fluorine in medicinal chemistry. J. Med. Chem. 51, 4359-4369.
12. Jeong S., Higuchi R., Ono M., Kuwano M., Kim Y. C., and Miyamoto T. (2003) cis-Hinokiresinol, a norlignan from Anemarrhena asphodeloides, inhibits angiogenic response in vitro and in vivo. Biol. Pharm. Bull. 26, 1721-1724.
13. Kaessler A., Algul O., and Jose J. (2007), A microplate based screening of benzimidazole derivatives on hyaluronidase inhibition at pH 7 and 3.5. Lett. Drug Des. Discov. 4, 562-569.
14. Kaessler A., Nourrisson M. R., Duflos M., and Jose J. (2008), Indole carboxamides inhibit bovine testes hyaluronidase at pH 7.0 and indole acetamides activate the enzyme at pH 3.5 by different mechanisms. J. Enzym. Inhib. Med. Chem. 23, 719-727.
15. Khanum S. A., Murari S. K., Vishwanath B. S., and Shashikanth S. (2005), Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes. Bioorg. Med. Chem. Lett. 15, 4100-4104.
16. Laird A. D., Christensen J. G., Li G., Carver J., Smith K., Xin X., Moss K. G., Louie S. G., Mendel D. B., and Cherrington J. M. (2002), SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. FASEB J. 16, 681-690.
17. Laurent T. and Fraser J. (1992), Hyaluronan. FASEB J. 6, 2397-2405.
18. Laurent T. C., Laurent U. B., and Fraser J. R. (1996), The structure and function of hyaluronan: An overview. Immunol. Cell. Biol. 74, A1-A7.
19. Liu D. (1996), Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 93, 7832-7837.
20. Liu Y., Shi T., Wang Y., Yang H., Yan X., Luo X., Jiang H., and Zhu W. (2009), Halogen bonding-A novel interaction for rational drug design. J. Med. Chem. 52, 2854-2862.
21. Maingonnat C., Victor R., Bertrand P., Courel M. N., Mounoury R., and Delpech B. (1999), Activation and inhibition of human cancer cell hyaluronidase by proteins. Anal. Biochem. 268, 30-34.
22. Olgen S., Kaesler A., Nebioglu D., and Jose J. (2007), New potent indole derivatives as hyaluronidase inhibitors. Chem. Biol. Drug Des. 70, 547-551.
23. Rigden D. J., Botzki A., Nukui M., Mewbourne R. B., Lamani E., Braun S., von Angerer E., Bernhardt G., Dove S., Buschauer A., and Jedrzejas M. J. (2006), Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole. Glycobiology 16, 757-765.
24. Stern R. and Jedrzejas M. J. (2006), Hyaluronidases: Their genomics, structures, and mechanisms of action. Chem. Rev. 106, 818-839.
25. Toida T., Ogita Y., Suzuki A., Toyoda H., and Imanari T. (1999), Inhibition of hyaluronidase by fully Osulfonated glycosaminoglycans. Arch. Biochem. Biophys. 370, 176-182.
26. Trochon V., Blot E., Cymbalista F., Engelmann C., and Tang R. P. (2000), Apigenin inhibits endothelial cell proliferation in g2/m phase whereas it stimulates smooth-muscle cells by inhibiting p21 and p27 expression. Int. J. Cancer 85, 691-696.